Advertisement

Colorectal Carcinoma

  • Maurice B. LoughreyEmail author
Chapter
  • 44 Downloads

Abstract

Colorectal Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.

Keywords

Colorectal adenocarcinoma Familial adenomatous polyposis Lynch syndrome Mismatch repair Immunohistochemistry TNM8 

Bibliography

  1. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK et al. (eds). American Joint Cancer Committee Cancer Staging Manual. Switzerland: Springer International Publishing; 2017.Google Scholar
  2. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Bateman AC, Carr NJ, Warren BF. The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin? J Clin Pathol. 2005;58:426–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Betge J, Pollheimer MJ, Lindtner RA, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012;118:628–38.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013;62:376–86.CrossRefGoogle Scholar
  6. Bosch SL, Teerenstra S, de Wilt JH, Cunningham C, Nagtegaal ID. Predicting lymph node metastasis in pT1 colorectal cancer: A systematic review of risk factors providing rationale for therapy decisions. Endoscopy. 2013;45:827–34.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Bosman FT, Carneiro F. GI WHO classification of tumours. Digestive system tumours. 5th ed.; 2019.Google Scholar
  8. Brierley JD, Gospodarowicz MK, Wittekind C. UICC TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2017.Google Scholar
  9. Brown IS, Bettington ML, Bettington A, Miller G, Rosty C. Adverse histological features in malignant colorectal polyps: A contemporary series of 239 cases. J Clin Pathol. 2016;69:292–9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Bull AD, Biffin AHB, Mella J, Radcliffe AG, Stamatakis JD, Steele RJC, Williams GT. Colorectal cancer pathology reporting: a regional audit. J Clin Pathol. 1997;50:138–42.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Burroughs SH, William GT. Examination of large intestine resection specimens. J Clin Pathol. 2000;50:344–9.CrossRefGoogle Scholar
  12. Cairns SR, Scholefield JH, Steele RJ, on behalf of the British Society of Gastroenterology, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–09.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Chetty R. Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas. J Clin Pathol. 2012;65:1062–5.CrossRefGoogle Scholar
  14. Cooper HS, Deppisch LM, Kahn EI, Lev R, Manley PN, Pascal RR, Qizilbash AH, Rickert RR, Silverman JF, Wirman JA. Pathology of the malignant colorectal polyp. Hum Pathol. 1998;29:15–26.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Cooper HS. Pathology of the endoscopically removed malignant colorectal polyp. Curr Diagn Pathol. 2007;13:423–37.CrossRefGoogle Scholar
  16. Cserni G, Bori R, Sejben I. Limited lymph-node recovery based on lymph-node localisation is sufficient for accurate staging. J Clin Pathol. 2011;64:13–5.CrossRefGoogle Scholar
  17. Dirschmid K, Sterlacci W, Oellig F, Edlinger M, Jasarevic Z, Rhomberg M, Dirschmid H, Offner F. Absence of extramural venous invasion is an excellent predictor of metastasis-free survival in colorectal carcinoma stage II – a study using tangential tissue sectioning. J Clin Pathol. 2012;65:619–23.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958;12:309–20.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Ensari A, Bosman FT, Offerhaus GJA. The serrated polyp: getting it right! J Clin Pathol. 2010;63:665–8.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 454 cases. Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179–89.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350–6.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterol. 1985;89:328–36.CrossRefGoogle Scholar
  23. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113–30.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID. Perineural invasion is a strong prognostic factor in colorectal cancer: A systematic review. Am J Surg Pathol. 2016;40:103–12.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Littleford SE, Baird A, Rotimi O, Verbeke CS, Scott S. Interobserver variation in the reporting of local peritoneal involvement and extramural venous invasion in colonic cancer. Histopathology. 2009;55:407–13.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Loughrey MB, Quirke P, Shepherd NA. Standards and datasets for reporting cancers: Dataset for colorectal cancer histopathology reports. Version 4. London: Royal College of Pathologists; 2018.Google Scholar
  27. Ludeman L, Shepherd NA. Macroscopic assessment and dissection of colorectal cancer resection specimens. Curr Diagn Pathol. 2006;12:220–30.CrossRefGoogle Scholar
  28. Lugli A, Kirsch R, Ajioka Y, et al. Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016. Mod Pathol. 2017;30:1299–311.CrossRefPubMedPubMedCentralGoogle Scholar
  29. MacGregor TP, Maughan TS, Sharma RA. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now. J Clin Pathol. 2012;65:867–71.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2007;50:131–50.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Mekenkamp LJM, van Krieken JHJM, Marijnen CAM, van de Velde CJH, Nagtegaal ID. Lymph node retrieval in rectal cancer is dependent on many factors – the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 2009;33:1547–53.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Mitchard JR, Love SB, Baxter KJ, Shepherd NA. How important is peritoneal involvement in rectal cancer? A prospective study of 331 cases. Histopathology. 2010;57:671–9.CrossRefPubMedPubMedCentralGoogle Scholar
  33. McGregor DK, Wu TT, Rashid A, Luthra R, Hamilton SR. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol. 2004;28:712–8.CrossRefPubMedPubMedCentralGoogle Scholar
  34. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study. BMJ. 2006;333:779.Google Scholar
  35. Nagtegaal ID, Knijn N, Hugen N, et al. Tumor deposits in colorectal cancer: Improving the value of modern staging-A systematic review and meta-analysis. J Clin Oncol. 2016;35:1119–27.CrossRefPubMedPubMedCentralGoogle Scholar
  36. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut. 2011;60:116–29.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;ii:996–8.CrossRefGoogle Scholar
  38. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821–8.Google Scholar
  39. Riddell RH, Goldman H, Ransonoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SK, Morson BC, Sommers SC, Yardley JH. Dysplasia in inflammatory bowel disease: standardised classification with provisional clinical applications. Hum Pathol. 1983;14:931–68.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Ryan R, Gibbons D, Hyland JMP, Treanor D, White A, Mulcahy HE, O’Donoghue DP, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47:141–6.CrossRefPubMedPubMedCentralGoogle Scholar
  41. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–5.CrossRefPubMedPubMedCentralGoogle Scholar
  42. Sepulveda AR, Hamilton SR, Allegra CJ, et al. Molecular biomarkers for the evaluation of colorectal cancer: Guideline from the american society for clinical pathology, college of american pathologists, association for molecular pathology, and american society of clinical oncology. J Mol Diagn. 2017;19:187–225.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Shepherd NA, Baxter KJ, Love SB. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol. 1995;48:849–55.CrossRefPubMedPubMedCentralGoogle Scholar
  44. Shepherd NA, Warren BF, Williams GT, Greenson JK, Lauwers GY, Novelli MR. Morson & Dawson’s gastrointestinal pathology. 5th ed. Oxford: Wiley-Blackwell; 2013.CrossRefGoogle Scholar
  45. Sloothaak DA, Sahami S, van der Zaag-Loonen HJ, et al. The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2014;40:263–9.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Stewart CJR, Morris M, de Boer B, Iacopetta B. Identification of serosal invasion and extramural venous invasion on review of Dukes’ stage B colonic carcinomas and correlation with survival. Histopathology. 2007;51:372–8.CrossRefPubMedPubMedCentralGoogle Scholar
  47. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJR, Morson BC. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology. 1981;5:141–63.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Verhulst J, Ferdinande L, Demetter P, Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012;65:381–8.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Williams GT. Endocrine tumours of the gastrointestinal tract – selected topics. Histopathology. 2007;50:30–41.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Wittekind C, Compton C, Quirke P, et al. A uniform residual tumor (R) classification: Integration of the R classification and the circumferential margin status. Cancer. 2009;115:3483–8.CrossRefPubMedPubMedCentralGoogle Scholar
  51. Xu F, Xu J, Lou Z, Di M, Wang F, Hu H, Lai M. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 stages and decreased survivial time in TNM stages I and II. Am J Surg Pathol. 2009;33:1287–92.CrossRefPubMedPubMedCentralGoogle Scholar
  52. Yao Y-F, Wang L, Liu Y-Q, Li J-Y, Gu J. Lymph node distribution and pattern of metastases in the mesorectum following total mesorectal excision using the modified fat clearing technique. J Clin Pathol. 2011;64:1073–7.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute of Pathology, Royal Victoria HospitalBelfastUK

Personalised recommendations